VolitionRX Limited (VNRX): Price and Financial Metrics

VolitionRX Limited (VNRX)

Today's Latest Price: $3.10 USD

0.01 (-0.32%)

Updated Apr 1 6:40pm

Add VNRX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

VNRX Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for VNRX is 0 -- better than just 7.83% of US stocks.
  • Of note is the ratio of Volitionrx Ltd's sales and general administrative expense to its total operating expenses; merely 18.81% of US stocks have a lower such ratio.
  • VNRX's price/sales ratio is 8,435.68; that's higher than the P/S ratio of 99.98% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Volitionrx Ltd are TGTX, NK, AUPH, VHC, and ADVM.
  • VNRX's SEC filings can be seen here. And to visit Volitionrx Ltd's official web site, go to volitionrx.com.
VNRX Daily Price Range
VNRX 52-Week Price Range

VNRX Stock Price Chart More Charts

VNRX Price/Volume Stats

Current price $3.10 52-week high $6.84
Prev. close $3.11 52-week low $2.22
Day low $3.00 Volume 102,000
Day high $3.22 Avg. volume 154,362
50-day MA $3.96 Dividend yield N/A
200-day MA $4.38 Market Cap 127.74M

VolitionRX Limited (VNRX) Company Bio

VolitionRX Limited, a clinical-stage life sciences company, focuses on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The company is based in Singapore.

VNRX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

VNRX Latest Social Stream

Loading social stream, please wait...

View Full VNRX Social Stream

VNRX Price Returns

1-mo -18.85%
3-mo -35.42%
6-mo -43.01%
1-year -3.43%
3-year -24.57%
5-year -24.39%
YTD -34.60%
2019 161.88%
2018 -38.44%
2017 -35.67%
2016 1.56%
2015 15.38%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8788 seconds.